COVID 19 News and Research

RSS

Driving up the immune response at tumor site may help boost immunotherapy

Driving up the immune response at tumor site may help boost immunotherapy

Driving up the immune response at the site of a cancer tumor with nanotechnology may help enhance immunotherapy treatments in advanced stages of the disease, new research in mice suggests.

15 Dec 2021

Rapid 2D barcode rack scanners help lower the cost of COVID-19 PCR testing

Rapid 2D barcode rack scanners help lower the cost of COVID-19 PCR testing

Ziath reports how its super-fast 2D barcode rack readers are assisting leading COVID-19 testing lab – SummerBio LLC (Menlo Park, California, USA) to offer rapid, low-cost, high-volume testing solutions for educational organizations, employers and laboratories.

From Ziath Ltd 15 Dec 2021

Study details the design of RNA-based breathalyzer to diagnose SARS-CoV-2

Study details the design of RNA-based breathalyzer to diagnose SARS-CoV-2

In a new study in The Journal of Molecular Diagnostics, published by Elsevier, investigators report on the design and testing of a breathalyzer, known as the Bubbler, that relies on viral RNA detection to diagnose SARS-CoV-2. Its name is derived from the bubbling sound that occurs when the patient exhales into the device.

14 Dec 2021

Why is Innovation Critical to Life Sciences Research?

Why is Innovation Critical to Life Sciences Research?

In this interview, we speak to Kirstie Speck from Abcam about the importance of innovation within the life sciences and how its role will change over the next 10 years.

From Abcam 13 Dec 2021

Study helps identify how immune system cells identify and eradicate tumors

Study helps identify how immune system cells identify and eradicate tumors

In the last 10 years, immunotherapy has been used to save the lives of several cancer patients with lung cancer.

13 Dec 2021

Cocktails of llama nanobodies effective against COVID-19 variants, says study

Cocktails of llama nanobodies effective against COVID-19 variants, says study

According to recent research, cocktails of small llama antibodies against SARS-CoV-2—the causative agent of COVID-19—can help fight novel variants of the virus.

13 Dec 2021

Multiple exposure enhances antibody efficacy against COVID-19 variants

Multiple exposure enhances antibody efficacy against COVID-19 variants

Antibodies produced by the immune system against the SARS-CoV-2 spike protein help pinpoint and avoid future infections.

13 Dec 2021

Powering the Biotechnology Revolution through Cloud R&D

Powering the Biotechnology Revolution through Cloud R&D

In this interview, we speak to Sajith Wickramasekara, CEO and Co-Founder of Benchling, about cloud R&D and how it is powering the biotechnology revolution.

From Benchling 10 Dec 2021

Robust biosecurity system essential as Australian agriculture industry set to make history

Robust biosecurity system essential as Australian agriculture industry set to make history

The Australian agriculture industry is set to make history this financial year with a forecast to reach $78 billion in value.

9 Dec 2021

Study uncovers an immune evasion mechanism of SARS-CoV-2

Study uncovers an immune evasion mechanism of SARS-CoV-2

Scientists discovered that SARS-CoV-2 can knock out a significant molecular pathway associated with an immune complex named MHC class I.

8 Dec 2021

Lunaphore highlights novel spatial biology research at SITC 2021

Lunaphore highlights novel spatial biology research at SITC 2021

Lunaphore today announced new research from collaborators at the University of Birmingham.

From Lunaphore 7 Dec 2021

Metabolites from human microbiome can inhibit COVID-19 infection, says study

Metabolites from human microbiome can inhibit COVID-19 infection, says study

Scientists recently discovered metabolites in the human microbiome that hinders COVID-19 infection in cell-based models of the virus.

7 Dec 2021

Research team grows mini-stomach across varying stages of development

Research team grows mini-stomach across varying stages of development

A group of researchers led from Great Ormond Street Hospital (GOSH) hinged on recent progress to culture “mini-organs” in a lab, called organoids.

From University College London 7 Dec 2021

Duke engineers develop a rapid test to identify antibody effectiveness against COVID-19 variants

Duke engineers develop a rapid test to identify antibody effectiveness against COVID-19 variants

Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person's neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.

6 Dec 2021

New nanoparticle adjuvant could lead to more powerful vaccines

New nanoparticle adjuvant could lead to more powerful vaccines

A common strategy to make vaccines more powerful is to deliver them along with an adjuvant -; a compound that stimulates the immune system to produce a stronger response.

6 Dec 2021

Creating a Biological Clock in a Test Tube

Creating a Biological Clock in a Test Tube

We speak to researchers from the UC San Diego Center for Circadian Biology about their latest research that led to the development of a biological clock in a test tube.

From UC San Diego 6 Dec 2021

Experts create new software that determines a person’s past infections

Experts create new software that determines a person’s past infections

Recent research suggested that grouping of pathogen-recognizing proteins on immune T cells might be vital in pinpointing if an individual had an infection in the past.

2 Dec 2021

Cytomegalovirus accelerates the decline of the immune system regardless of age

Cytomegalovirus accelerates the decline of the immune system regardless of age

Scientists from the University of Córdoba have been investigating the changes that occur in the T lymphocytes of the immune system with increasing age.

2 Dec 2021

New CRISPR technology could improve diagnostic tests for COVID-19

New CRISPR technology could improve diagnostic tests for COVID-19

A new type of CRISPR platform that leverages the benefits of a compact RNA-editing protein could result in enhanced diagnostic tests for COVID-19.

2 Dec 2021

Study analyzes response of individuals from diverse populations to infections

Study analyzes response of individuals from diverse populations to infections

A recent study has identified differences in immune pathway activation to influenza infection between people of European and African genetic ancestry.

2 Dec 2021

Previous
1
...
18
19
20
21
22
23
24
...
38
Next

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.